Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
ii saying they have contacted TILS on a number of occasions about this but no response or timetable has been forthcoming.
The TILS shareholder document from September last year which outlines the process for the demerger of Accustem contains the following statement in the Q&A on page 28:
"12. When will the Demerger come into effect?
With the necessary approvals, it is expected the Demerger will be completed no later than on
30 October 2020. The Accustem Shares are expected to be admitted to the Official List and to
trading on the main market of the London Stock Exchange, and therefore capable of being
traded, later in Q4 2020. Accustem Shares will be allotted to you upon completion of the
Demerger but no share certificates will be issued nor CREST accounts credited until Accustem
Admission, or, if earlier, two months after completion of the Demerger."
As far as I am aware the Accustem shares have been allotted (they appear in my HL account as an allotted entitlement at zero value), but I haven't seen any confirmation that the shares have actually been issued which, according to the above, should have occurred two months after the demerger completed on 30 October 2020 (given that the Admission of Accustem shares didn't happen before the two month period came to an end).
This is not ideal - it really is up to the the TILS/Accustem boards to sort it out. In theory, if the Accustem Admission never actually occurred, we should at least have legal ownership of issued but unlisted Accustem shares.
I may have missed something here, so if anyone has a different take please do comment.
All rather clumsy really. Still, I am sure it will all be fine over the next few weeks.
currently there has been a capital reduction effective 29th October 2020; an asset with a tangible value has been divested from the Company but the Company has not compensated Shareholders.
"The Demerger is expected to become effective on 30 October 2020 and it is expected that Accustem Admission will occur later in Q4, 2020."
I'm very patient but the Company have either let Shareholders down badly or deliberately deceived them.
I've had a share of a valuable asset that I own taken from me and I'd like it back.
Supposedly by end of Q1, so hopefully listed by end of Month
I’m still waiting , I thought we were getting in March pal
Accustem news anyone?